INFORMATION BY CANCER TYPE

Liver

Opdivo Granted Priority Review to Treat Liver Cancer
BY Jason M. Broderick
Opdivo (nivolumab) was granted a priority review designation by the Food and Drug Administration (FDA) to treat some patients with liver cancer.
Stivarga Gains FDA Approval for Liver Cancer
BY Jason M. Broderick
The Food and Drug Administration (FDA) has approved Stivarga as a second-line treatment for patients with unresectable hepatocellular carcinoma (HCC) who have previously received Nexavar.
Knowledge is Power: Especially if it can help prevent disease
BY Debu Tripathy, MD

Understanding liver cancer is a crucial step toward the prevention of this rare condition.

Changing Direction on Liver Cancer Trends
BY AIMEE SWARTZ
Liver cancer diagnoses and mortality have been rising, but new treatments are designed to help reverse the trend.
Frontline Lenvima Is Noninferior to Standard Therapy in Liver Cancer Trial
BY Jason M. Broderick
A recent phase 3 trial showed that treatment with Lenvima is noninferior to standard treatment for patients with unresectable liver cancer.
 
 
Multikinase Inhibitor Gets Priority Review in Liver Cancer
BY Jason M. Broderick
Stivarga was granted a priority review by the FDA to treat certain patients with liver cancer in the second line setting. 
Targeted Therapy Strikes Hope in Second-Line Liver Cancer
BY Laura Panjwani
Stivarga is being considered by the FDA for approval for second-line liver cancer treatment, renewing hope in the field. 
Trial Data May Change Standard Second-Line Treatment of Liver Cancer
BY Virginia Powers, PhD
After doing well in a phase 3 trial, Stivarga showed the potential to shift the treatment paradigm for previously treated liver cancer.
Expert Discusses What Advances to Expect in Liver Cancer
BY Greg Kennelty
Michael Choti talks about what kind of advances can be expected in treating liver cancer, including PD-1 inhibitors and neoadjuvant treatment.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Liver CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Primary Liver Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult primary liver cancer.
Childhood Liver Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood liver cancer.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Liver (Hepatocellular) Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.
Liver (Hepatocellular) Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing hepatocellular cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Liver (Hepatocellular) Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for liver (hepatocellular) cancer.
x